Mounjaro is a prescribed injectable medication designed to complement dietary and exercise routines, aiming to enhance blood sugar (glucose) levels in adults diagnosed with type 2 diabetes mellitus.
Its suitability for individuals with a history of pancreatitis remains uncertain. Notably, Mounjaro is not intended for individuals with type 1 diabetes. Additionally, its safety and efficacy have not been established for use in children under 18 years of age.
